Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients
Clinical and Translational Allergy · 2025-01 · 15 (1)
DOI: 10.1002/clt2.70026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Allergy, online erschienen am 03.01.2025. Verfasst von Sophia Neisinger und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berl…. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patient‐reported outcome measures (PROMs) help to assess disease control and quality of life (QoL) in chronic spontaneous urticaria (CSU) and recurrent angioedema (RA). This study aimed to assess the correlation between two different concepts: disease control and QoL, using disease‐specific PROMs.
Methods
We analyzed data from 445 CSU and 330 RA patients who completed both a disease control and QoL PROM as part of the clinical routine. We included the UCT and CU‐Q2oL for CSU and AECT and AE‐QoL for RA.
Results
In CSU and RA, disease control scores positively correlated with QoL scores (Spearman's rho correlation coefficient (CR) −0.757, −0.735; p < 0.001) with better disease control corresponding to better quality of life. However, 5.9% of CSU patients and 28% of RA patients with complete disease control had impaired QoL. In CSU, QoL was impaired in 69.2% of patients based on the CU‐Q2oL and in 62.7% of patients based on a single numeric question from the UCT, with a mismatch in 89/445 patients. In RA, QoL was impaired in 58.5% using the AE‐QoL and in 52.7% using a single numeric question from the AECT30mo, with a mismatch in 69/330 patients. Different domains of the QoL PROMs showed different degrees of influence on disease control, with “Itching/Embarrassment” showing the strongest correlation with the UCT (CR −0.804; p < 0.001) and “Functioning” with the AECT3mo (CR −0.824; p < 0.001).
Conclusion
Although most patients with controlled disease have better quality of life, unexpectedly, quality of life remains impaired in up to one‐fourth of patients with completely controlled CSU and RA. Reasons behind this should be investigated in further studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
- Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology, Berlin, Germany.
- School of Medicine, Lebanese American University, Byblos, Lebanon.
- Institut National de Santé Publique d'Épidémiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon.
- Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus.
ORCID-Profile: Sophia Neisinger, Pascale Salameh, Annika Gutsche, Frank Siebenhaar, Marcus Maurer
Zitieren
APA
Neisinger, S., Salameh, P., Gutsche, A., Aulenbacher, F., Siebenhaar, F., & Maurer, M. (2025). Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients. Clinical and Translational Allergy, 15(1). https://doi.org/10.1002/clt2.70026
Vancouver
Neisinger S, Salameh P, Gutsche A, Aulenbacher F, Siebenhaar F, Maurer M. Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients. Clinical and Translational Allergy. 2025;15(1). doi:10.1002/clt2.70026
BibTeX
@article{Neisinger2025,
author = {Neisinger, Sophia and Salameh, Pascale and Gutsche, Annika and Aulenbacher, Felix and Siebenhaar, Frank and Maurer, Marcus},
title = {Disease control and quality of life in chronic spontaneous urticaria and recurrent angioedema are strongly linked, but not in all patients},
journal = {Clinical and Translational Allergy},
year = {2025},
volume = {15},
number = {1},
doi = {10.1002/clt2.70026}
}
EUVIMED